Investment Column: Copper market key to Kazakhmys shares - Sharewatch - Business - The Independent

Investment Column: Copper market key to Kazakhmys shares

AstraZeneca; Mitchells & Butlers


Our view: Cautious hold

Share price: 233.75p (-8.25p)

The good news from the Kazakhstan-based copper miner Kazakhmys yesterday was that production in 2008 hit targets.

This is a creditable performance, especially since the group had a tough first quarter. However, the company also announced that it was planning to cut production in the next year to take account of falling worldwide demand: while copper is great when things are going swimmingly, it is not the best metal to be mining when things turn sour. The price of copper has fallen by about 60 per cent since last summer, which is only slightly less awful than the 79 per cent drop in the value of Kazakhmys's shares in the last year.

There are a number of reasons why mining investors might fancy a punt, however. While the group will not say never, it is unlikely to be offering a rights issue, unlike Xstrata, which yesterday announced it is hoping to raise £4.1bn from shareholders.

Buyers are also in theory offered some protection against volatility by virtue of nearly 54 per cent of the group being held by the chairman, Vladimir Kim, and the Kazakh government, although the graph of the stock's performance somewhat undermines this particular thesis.

No matter how you dress it up, demand for copper, and therefore its price, is not likely to improve too much in the next few months, and possibly longer. The group has cut costs, and that will help, and it is also undervalued, say watchers at Citigroup. "After stripping out the value of ENRC [another Kazakh miner in which Kazakhmys has a 26 per cent share] and the power assets, the market is deeply discounting KAZ's copper assets relative to peers," Cazenove notes.

A bet on Kazakhmys is ultimately linked to a bet on the price of copper, and we would argue that it may stay depressed for a while. Cautious hold.

AstraZeneca

Our view: Buy

Share price: 2,680p (-180p)

It was not a great day for AstraZeneca shareholders or employees yesterday. The stock fell 6.3 per cent as the UK's second biggest drugs group announced its full-year results, saying that 2008 profits were up 13 per cent, while the group confirmed that it is axing 6,000 jobs over the next four years.

Investors have long been told that the pharmaceutical sector is good for their financial health in the midst of the recession: people still fall ill, and with drugs paid for by the state, or medical insurance, treatments cannot be considered a discretionary spend. Buyers of AstraZeneca shares have celebrated a 33 per cent rise in the stock over the last 12 months, which ranks as one of the best performers on the FTSE 100.

Investors should note, however, that operating profits were down yesterday after the company said asset impairment charges, including a $115m charge relating to its Pulmicort Respules, hit core profits, and while this does little for the numbers, investors should wonder whether this will be detrimental to the stock in the longer run.

A worry for all pharma groups is the threat posed by generic competition, with some watchers saying that the pipeline of new drugs cannot grow fast enough to offset the rate of patents expiring. Nonetheless, there is still value in the stock, which trades at a 28 per cent discount to the European pharma industry, according to analysts at Cazenove, and the sector is still likely to provide respite from more toxic sectors. The dividend is also up, and that should clinch it for anyone in doubt. Buy.

Mitchells & Butlers

Our view: Hold for now

Share price: 187.5p (+1p)

"It should be a winner," say watchers at Evolution of the pub group Mitchells & Butlers, which owns the All Bar One chain. Like Greene King yesterday, the company is one of the few pub groups that investors should consider, in what is otherwise a pretty nasty sector.

The group issued an update yesterday saying that trading in the 17 weeks to 24 January was "resilient, against a worsening trend of consumer demand, with like-for-like sales up 1 per cent". This really is a rather good performance, with a host of industry analysts lining up to recommend the group to clients. "Recessionary pressures are intensifying, beer sales are under pressure, costs are annoying and consumer demand is weakening. Nonetheless, M&B is well-positioned, is taking market share and... trades on about 9 times this year's earnings per share," say those at Blue Oar.

The problem that investors should seriously consider is that, like all other pub groups, the company is dependent on discretionary sales, and with the economy heading further south, at an increasing rate, we are nervous about the sector as a whole. We like Mitchells & Butlers, but we dislike the sector even more, and therefore would be cautious about any of the industry's stocks. That said, a general recovery should lead to a big boost for those holding the stock. Hold for now.

News
Paper trail: the wedding photograph found in the rubble after 9/11 – it took Elizabeth Keefe 13 years to find the people in it
newsWho are the people in this photo? It took Elizabeth Stringer Keefe 13 years to find out
Arts and Entertainment
Evil eye: Douglas Adams in 'mad genius' pose
booksNew biography sheds light on comic genius of Douglas Adams
Sport
FootballFull debuts don't come much more stylish than those on show here
News
i100
PROMOTED VIDEO
Life and Style
Kim Kardashian drawn backlash over her sexy swimsuit selfie, called 'disgusting' and 'nasty'
fashionCritics say magazine only pays attention to fashion trends among rich, white women
Arts and Entertainment
TVShows like Agents of S.H.I.E.L.D are little more than marketing tools
Arts and Entertainment
Hit the roof: hot-tub cinema east London
architectureFrom pools to football pitches, rooftop living is looking up
Travel
travel
News
The ecological reconstruction of Ikrandraco avatar is shown in this illustration courtesy of Chuang Zhao. Scientists on September 11, 2014 announced the discovery of fossils in China of a type of flying reptile called a pterosaur that lived 120 millions years ago and so closely resembled those creatures from the 2009 film, Avatar that they named it after them.
SCIENCE
Life and Style
tech
News
ebooksAn unforgettable anthology of contemporary reportage
Arts and Entertainment
Matisse: The Cut-Outs exhibition attracted 562,000 visitors to the Tate Modern from April to September
art
Life and Style
Models walk the runway at the Tom Ford show during London Fashion Week Spring Summer 2015
fashionLondon Fashion Week 2014
News
Kenny G
news
News
peopleThe black actress has claimed police mistook her for a prostitute when she kissed her white husband
Life and Style
techIndian model comes with cricket scores baked in
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SQL Developer - Watford/NW London - £280 - £320 p/d - 6 months

£280 - £320 per day: Ashdown Group: The Ashdown Group have been engaged by a l...

Senior BA - Insurance **URGENT**

£400 - £450 Per Day: Clearwater People Solutions Ltd: **URGENT CONTRACT ROLE**...

Training Coordinator / Resource Planner - City, London

£35000 - £38000 per annum + Benefits: Ashdown Group: Training Coordinator / Pl...

Data Governance Manager (Solvency II) – Contract – Up to £450 daily rate, 6 month (may go Permanent)

£400 - £450 Per Day: Clearwater People Solutions Ltd: We are currently looking...

Day In a Page

Mystery of the Ground Zero wedding photo

A shot in the dark

Mystery of the wedding photo from Ground Zero
His life, the universe and everything

His life, the universe and everything

New biography sheds light on comic genius of Douglas Adams
Save us from small screen superheroes

Save us from small screen superheroes

Shows like Agents of S.H.I.E.L.D are little more than marketing tools
Reach for the skies

Reach for the skies

From pools to football pitches, rooftop living is looking up
These are the 12 best hotel spas in the UK

12 best hotel spas in the UK

Some hotels go all out on facilities; others stand out for the sheer quality of treatments
These Iranian-controlled Shia militias used to specialise in killing American soldiers. Now they are fighting Isis, backed up by US airstrikes

Widespread fear of Isis is producing strange bedfellows

Iranian-controlled Shia militias that used to kill American soldiers are now fighting Isis, helped by US airstrikes
Topshop goes part Athena poster, part last spring Prada

Topshop goes part Athena poster, part last spring Prada

Shoppers don't come to Topshop for the unique
How to make a Lego masterpiece

How to make a Lego masterpiece

Toy breaks out of the nursery and heads for the gallery
Meet the ‘Endies’ – city dwellers who are too poor to have fun

Meet the ‘Endies’ – city dwellers who are too poor to have fun

Urbanites are cursed with an acronym pointing to Employed but No Disposable Income or Savings
Paisley’s decision to make peace with IRA enemies might remind the Arabs of Sadat

Ian Paisley’s decision to make peace with his IRA enemies

His Save Ulster from Sodomy campaign would surely have been supported by many a Sunni imam
'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

Exclusive extract from Janis Winehouse's poignant new memoir
Is this the role to win Cumberbatch an Oscar?

Is this the role to win Cumberbatch an Oscar?

The Imitation Game, film review
England and Roy Hodgson take a joint step towards redemption in Basel

England and Hodgson take a joint step towards redemption

Welbeck double puts England on the road to Euro 2016
Relatives fight over Vivian Maier’s rare photos

Relatives fight over Vivian Maier’s rare photos

Pictures removed from public view as courts decide ownership
‘Fashion has to be fun. It’s a big business, not a cure for cancer’

‘Fashion has to be fun. It’s a big business, not a cure for cancer’

Donatella Versace at New York Fashion Week